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Abstract
Fragile X syndrome (FXS) is one of the most common known causes of inherited mental retardation. The gene mutated in
FXS is named FMR1, and is well conserved from human to Drosophila. In order to generate a genetic tool to study FMR1
function during vertebrate development, we generated two mutant alleles of the fmr1 gene in zebrafish. Both alleles
produce no detectable Fmr protein, and produce viable and fertile progeny with lack of obvious phenotypic features. This is
in sharp contrast to published results based on morpholino mediated knock-down of fmr1, reporting defects in craniofacial
development and neuronal branching in embryos. These phenotypes we specifically addressed in our knock-out animals,
revealing no significant deviations from wild-type animals, suggesting that the published morpholino based fmr1
phenotypes are potential experimental artifacts. Therefore, their relation to fmr1 biology is questionable and morpholino
induced fmr1 phenotypes should be avoided in screens for potential drugs suitable for the treatment of FXS. Importantly, a
true genetic zebrafish model is now available which can be used to study FXS and to derive potential drugs for FXS
treatment.
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Introduction
Fragile X syndrome (FXS) is one of the most common known
causes of inherited mental retardation with a frequency of 1:4000
males and 1:6000 females [1]. In almost all cases, FXS is due to
the expansion of the unstable CGG trinucleotide repeat sequence
in the 59 untranslated region of the FMR1 gene [2,3]. Once the
repeats exceed 200 units (full mutation), the gene is silenced due to
the consequent hypermethylation of the CpG island and CGG
repeat. Thus, no mRNA is produced, and the lack of the gene
product, FMRP, is responsible for the mental retardation in fragile
X patients [4]. Other clinical features include macroorchidism,
autistic behaviour, epileptic seizures, hyperactivity, attention
deficits and mild craniofacial abnormalities [1].
FMRP is a ubiquitously expressed RNA-binding protein,
including two KH domains and an RGG box, with high
expression levels in brain and testis [5,6]. The protein can bind
to RNAs containing a G-quartet structure and forms together with
many other mRNAs and proteins a messenger ribonucleoprotein
(mRNP) particle [7,8]. The dynamics and transport of mRNP
particles over long distances within the dendrites of neurons is
established by movement along microtubules [9].
The development of mouse models of FXS has facilitated
cellular studies on the underlying molecular basis of this loss-of-
function disorder [10,11]. Fmr1 knock-out mice recapitulate the
typical characteristics of FXS, including behavioural abnormali-
ties, learning deficits and audiogenic seizures. Microscopic analysis
of brain material from both FXS patients and Fmr1 knockout mice
has shown dendritic spine abnormalities [12–17]. The discovery of
a spine morphological phenotype indicates a possible defect in
synaptic plasticity in FXS. The precise physiological function of
FMRP is still not defined; therefore, the role of FMRP at the
synapse has become a central research interest. Compelling
evidence predicts a model in which FMRP is involved in the
regulation (repression) of local protein synthesis at the synapse,
which is triggered group 1 mGluR (mGluR1 and mGluR5)
activation. Thus, a lack of FMRP may lead to uncontrolled
(exaggerated) protein synthesis at the synapse upon group 1
mGluR stimulation and may underlie the enhanced hippocampal
and cerebellar LTD found in Fmr1 knock-out mice [16,18,19].
Interestingly, some behavioural abnormalities could be rescued in
Fmr1 knock-out mice using mGluR5 antagonists [20,21]. Recently,
a rescue of the spine morphological phenotype could be
established in cultured Fmr1 knock-out hippocampal neurons
using two different mGluR5 antagonists [21].
In 2006, Tucker et al. reported the use of zebrafish embryos to
model FXS [22]. Instead of a knock-out approach, a knock-down
strategy was applied using microinjection of morpholinos (MOs)
into 1–2 cell stage embryos. MOs are antisense oligonucleotides, in
which the deoxyribose is substituted with an N-morpholino ring.
They can bind to a target mRNA and prevent either translation or
normal splicing for up to 4 days. Hence, inhibition of translation is
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Injection of fmr1 specific MOs resulted in abnormal axonal
branching, changes in trigeminal ganglion number and craniofa-
cial abnormalities. Most of these abnormalities in zebrafish
embryos could be rescued using MPEP, an mGluR5 antagonist,
or by fmr1 overexpression [22].
In the present study, we generated two independent fmr1 knock-
out alleles using TILLING (targeted induced local lesions in
genomes). TILLING combines random induced mutations by
ENU treatment and subsequent screening for null mutations [23].
We provide a characterization of both homozygous and
transheterozygous mutants with special emphasis on the pheno-
typic features reported earlier in the fmr1 knock-down study [22].
Results
Isolation of Two Fmr1 Mutant Alleles
In order to develop a genetic model in which the effects of FMRP
on brain development can be easily studied during development we
screened for knock-out alleles in the zebrafish system. From a
randomly mutagenized library we isolated two independent mutant
alleles: hu2787 defines a C to T change in the coding region of fmr1
(ENSDARG00000037433), leading to the introduction of a
premature stop at codon position 113 (Figure 1A). The mRNA
derived from this allele is less stable than that derived from the wild-
type fmr1 locus. This is illustrated in Figure 1B using whole mount in
situ hybridisation with an fmr1 specific probe, on a batch of embryos
obtained from a cross between heterozygous parents. Presumably
this is the result from a well-known phenomenon named nonsense-
mediated-decay (NMD). Furthermore, using a C-terminal antibody
we are unable to detect expression of Fmr in neurons using
immunocytochemistry on paraffin sections, whereas a high
expression could be detected in neurons from wild type zebrafish.
Figure 1C illustrates high Fmr expression in Purkinje cells in the
cerebellum and neurons in the telencephalon. In addition, we
determined Fmr expression in total brain homogenates by Western
blot analysis. Consistent with the immuno-stainings, no Fmr was
detectable (Figure 1D). The second allele we isolated, hu2898, has a
mutated splice acceptor site at the end of the 7th intron. Sequencing
of splicing products from this allele shows that hu2898 leads to the
use of an alternative splice acceptor site 2 bases downstream of the
original site. This induces a frameshift with regard to the original
reading frame and an opal stop codon 27 nucleotides downstream
(Figure 1A). Animals carrying any combination of the two mutant
alleles show loss of Fmr in both immunocytochemistry (Figure 1C)
and Western blot analysis (Figure 1D).
Fmr1 Mutant Zebrafish Are Viable
Animals lacking zygotic Fmr are found at Mendelian frequen-
cies in crosses between heterozygous parents. They display wild-
type development, and develop into fertile adults with no gross
abnormalities. Progeny from homozygous mutant parents were
also analyzed to check the potential effect of maternally provided
protein and/or mRNA on development. Also these maternal-
zygotic (MZ) mutant animals develop normally, and display no
obvious defects in behaviour or fertility. Importantly, we did not
observe selective pressure against homozygous mutant combina-
tions in any of the crosses we performed (not shown), strongly
suggesting that potentially lethal phenotypes are not repressed by
the presence of genetic modifiers in our genetic backgrounds.
Lack of Fmr1 Does Not Induce Craniofacial Defects
The results described above contrasts with morpholino induced
fmr1 knock-down studies that have been published before [22].
More specifically, it was demonstrated that these morphants
display aberrant expression of three markers: axial, dlx-2a and islet-
1. We therefore analyzed the expression of these genes by in situ
hybridisation in fmr1 MZ null embryos. The results of these
Figure 1. Fmr1 mutant alleles. A) Illustration of the fmr1 gene product. The different domains are indicated, along with the sites where isolated
mutant alleles will affect the protein. B) Whole mount in situ hybridisation with an fmr1 specific probe. C) Immuno staining of wild type and mutant
brain sections using Fmr specific antibodies. Some Purkinje cells in the mutant have been outlined. D) Brain lysates were analyzed by western blot,
using an Fmr specific antibody. Lanes 1 and 3 contain wild type samples. Lane 2 contains hu2787/hu2787 lysate. Lane 4 contains hu2787/hu2898
lysate. The upper arrow points at Fmr. The lower arrow points at an a-specific band that serves as a loading control.
doi:10.1371/journal.pone.0007910.g001
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differences between wild-type and fmr1 null embryos in any of the
analyses.
In addition, we measured the width of Meckel’s cartilage and
the angle it makes to the anterior-posterior axis, to address
whether these mutant animals develop abnormalities that may be
related to the craniofacial defects seen in fragile X patients, as
described in the morpholino knockdown morphants [22]. In both
the MZ homozygous stop mutants and embryos derived from
homozygous stop mutant mothers and homozygous splice mutant
fathers (not shown) the width as well as the angle of this structure is
indistinguishable from that in wild-type animals (Figure 2B).
Figure 2. Phenotypic assays on wild-type and fmr1 mutant embryos. A) Wild type and mutant embryos were analyzed using whole mount in
situ hybridisation using probes against dlx-2a, axial and islet-1. B) The width of Meckel’s cartilage was measured in wild type (n=9) and MZ fmr1
mutant (n=11) embryos. The angle of this structure with regard to the anterior-posterior axis was also measured in wild-type (n=6) and fmr1 mutant
(n=9) embryos. Indicated errors represent SD. C) Neurite branching was measured on Rohon-Beard neurites using the monoclonal antibody zn-12.
Plotted is the branching frequency per 1000 mm in both wild-type and MZ stop mutant embryos. In total n=25 neurites (wild-type) and n=28
neurites (MZfmr1) were traced in a total of 8 embryos of each genotype. Error bars represent SD.
doi:10.1371/journal.pone.0007910.g002
Fmr1 Mutant Zebrafish
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Branching Defects
Finally, Tucker et al [22] described a defect in neurite branching
in Rohon-Beard neurons in fmr1 morphant embryo’s. We
therefore analyzed the branching frequency of the Rohon-Beard
neurons, similar to what was reported by Tucker et al [22]. In
Figure 2C we show that also in this analysis we find no significant
difference between wild-type and MZ fmr1 stop mutant animals.
Discussion
We describe the generation of two fmr1 knockout alleles in
zebrafish, and as such provide a new genetic model system to study
FXS, a highly prevalent form of inherited mental retardation. FXS
is caused by the loss of the gene product of fmr1, Fmr. FXS models
have been described in multiple systems and from these models it
has become clear that FMRP is acting at the synapse to regulate
the translation of target mRNAs upon group 1 mGluR stimulation
and whose protein products mediate synaptic strength [16,18].
Fmr1 knock-out mice exhibit exaggerated translation of target
mRNAs at the synapse. Potentially, such a process can be well
affected by mGluR antagonists that would ameliorate the
phenotypic outcome of FXS [24].
Establishing a zebrafish model for FXS is very useful in this
context, as the zebrafish embryo is amenable to large scale, small
molecule drug screens. Supporting this idea was the finding that
morpholino induced knock-down of fmr1 (fmr1 morphant) in the
zebrafish led to embryonic phenotypes that could in principle be
used as a read-out in drug screens [22]. Tucker et al. [22] reported
neurite branching defects and changes in trigeminal ganglion
neuron number following fmr1 knock down [22]. Interestingly,
treatment with MPEP, an mGluR5 antagonist, rescued most of
these abnormalities, indicating a connection between mGluR5
signalling and fmr1 function in neurite branching and number of
trigeminal ganglion neurons. Furthermore, it suggested that small
molecule drug screens in the zebrafish may indeed be an affective
manner of finding bio-active lead-compounds that are good
starting points for developing drugs beneficial for FXS patients.
Tucker et al [22] also reported craniofacial dysmorphology as a
result of fmr1 knock-down, and this again could be rescued by
treatment with MPEP. This is a curious finding, since the role of
synaptic connections between neurons in cranial cartilage
development is to date totally unexplored, and hence it is not
clear whether indeed MPEP would be expected to affect
craniofacial defects caused by loss of Fmr.
We here characterize two fmr1 mutant alleles in the zebrafish,
both of which lead to loss of detectable Fmr. In contrast to the
above-mentioned MO study, however, we cannot find any gross
phenotypical effects caused by these alleles. We checked
specifically the above-mentioned phenotypes, craniofacial abnor-
malities and neurite branching phenotypes, but find no significant
differences between wild type and mutant siblings. Fmr1 mutant
fish are also completely fertile, and incrosses between homozygous
mutant males and females result in normally developing embryos,
indicating that maternally provided mRNA and/or protein is not
rescuing first generation fmr1 mutants.
What could be causing the observed phenotypes in the morphants
[22], when genetic fmr1 null animals do not display these defects?
First we explore why genetic mutation of fmr1 may miss FXS-
relevant phenotypes. Redundancy could potentially be an issue. The
morpholinos used could affect the fmr1 homologues fxr1 and fxr2,
which are both present in zebrafish. This seems unlikely, however,
given the factthesequence comparison betweenthemorpholinoand
fxr-1/2 genes shows very little complementarity. Fmr1 itself could be
duplicated in zebrafish. However, the most recent genome
annotation shows no indication of a duplicated fmr1 gene, and on
western blot we detect no protein in fmr1 homozygous mutant tissue.
This makes the presence of a closely related, functional fmr1 copy
unlikely. Finally, potential phenotypes may be rescued by modifier
loci; loci that genetically interact with fmr1 and of which particular
alleles may suppressphenotypestriggered by lossofFmr. Despite the
fact that our zebrafish strains show no sign of selection for or against
homozygous fmr1 mutants, this is an option that is difficult to
eliminate. Extensive outcrossing into the zebrafish strains used in the
studies by Tucker et al [22] would be required to test this hypothesis.
There is, however, a more likely potential explanation: the
morpholino-induced phenotypes may not be related to loss of Fmr.
Morpholino oligonucleotides are well known to cause phenotypes
unrelated to knock-down of the intended gene. In fact, 15–20% of
MOs used in zebrafishshow off-targeting effects that are mediated by
p53-induced apoptosis [25]. In the study from Tucker et al. [22] the
number of analyzed morphants is very limited. For instance, altered
dlx-2a,fgfr1 and axialexpression could only be observed in 17/30, 11/
30 and 3/30 fmr1 morphants, respectively; for neurite branching
phenotypes no numbers are given related to the penetrance of the
defect; injection of antibodies against alpha-acetylated tubulin
resulted in a dramatic axon defect only in 3/30 and axon
defasciculation in 13/30 fmr1 morphants. Finally, the craniofacial
dysmorphology could only be observed in 9/15 fmr1 morphants.
In summary, we find the loss of fmr1 in zebrafish at most induces
very subtle phenotypes that are not readily detectable using light-
microscopy and techniques like immunocytochemistry and in situ
hybridisation, at least in the strains used in our laboratory. It
remains well possible that subtle defects are induced by lesions in
fmr1, and that these may be used to develop sensitive and robust
essays to probe fmr1 function, which may in turn be used for
screening of small molecules libraries in order to find drugs
suitable for treatment of FXS. At present, however, we have to
conclude that the phenotypes as described by Tucker et al [22]
may be based on morpholino induced artefacts, and as such not
useful to study fmr1 function in the zebrafish.
Materials and Methods
Zebrafish Strains and Screening F1 ENU- Mutation Library
Adult zebrafish were bred and maintained under standard
conditions. Staging of embryos was according to Kimmel et al.
[26]. Embryos at different developmental stages were fixed with
4% PFA/PBS overnight.
ENU induced mutation library was screened for a mutation in
the fmr1 gene. Amplicons were designed for exon 5–6 and exon 7–9
and screened for mutation asdescribed [23].Fishwith mutant alleles
(fmr1
hu2787 (stop); fmr1
hu2898 (splice)) were outcrossed against TL and
crossed to obtain homozygous or transheterozygous embryos.
Immunocytochemistry Adult Brain
Adult zebrafish were sacrificed by euthanasia using high dose of
MS222, brains were dissected immediately and fixed overnight in
3% paraformaldehyde. The brains were embedded in paraffin
according to standard protocols. Sections (7 mm) were deparaffi-
nized, followed by antigen retrieval using microwave treatment in
0.01 M sodium citrate solution. Endogenous peroxidase activity
blocking and immunoincubationwas performed as described before
using polyclonal rabbit 758 antibodies against zebrafish Fmrp [27].
Western Blotting
Half brains (saggital) from adult zebrafish were homogenised in
500 ml HEPES-buffer (10 mM HEPES, 300 mM KCl, 3 mM
Fmr1 Mutant Zebrafish
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20, pH 7.6, with Complete protease inhibitor cocktail (Roche
Diagnostics), while kept on ice. After incubating the homogenates
on ice for 30 minutes, they were sonicated twice for 20 seconds.
Cell debris was spun down and the supernatant was collected.
Loading mix was added to 100 mg of protein, heated at 95uC for 5
minutes and loaded onto a 10% SDS-PAGE gel. After electro-
blotting the gel onto a nitrocellulose membrane, the membrane
was incubated overnight at 4uC with the rabbit polyclonal 758
antibody specific for zebrafish FMRP [27], in PBS-T with 5% milk
powder. The next day the membrane was incubated with a
horseradish peroxidase conjugated secondary antibody rabbit-a-
mouse (DAKO), allowing chemiluminescence detection with an
ECL KIT (Amersham).
In Situ Hybridisation
ISH experiment were performed as described in Thisse et al.
[28]. The RNA-probes were made according standard protocols.
Probes against fmr1 (EST-clone fy56do3.x1; IRBOp991C1010D
from RZPD, Berlin, Germany) from which the cDNA fragment
was cloned into pCS2plus;dlx-2a [29]; axial [30] and islet-1 [31]
were used in the described experiments. ISH to show NMD on the
hu2787 fmr1 allele was done in one batch, so that wild-type,
heterozygous and homozygous mutant embryos received identical
treatments. Embryos were genotyped afterwards, revealing a
consistent loss of fmr1 mRNA in homozygous hu2787 mutants.
Cartilage Staining
fmr1
hu2787 incross embryos (5 dpf) were Alcian blue stained
according to Neuhauss et al. [32]. The width and the angle of
Meckel’s cartilage were measured and embryos were genotyped.
Antibody Staining Embryos
For whole-mount immunohistochemistry, embryos were fixed
in 4% paraformaldehyde for four hours at RT, washed with PBT
and incubated overnight at 65uC in FST solution (50%
formamide, 2x SSC, 0.1% Tween-20). Next day, washed in
PBT and blocked in ABS (PBT, 2% DMSO, 0.1% IGEPAL, 2%
lamb serum, 2% BSA) and incubated overnight with the
monoclonal antibody zn-12 (1:200, Developmental Studies
Hybridoma Bank). Primary antibody was washed off by ABS
buffer, and embryos were incubated overnight with secondary
antibody goat anti-mouse conjugated with Alexa-488 (1:250,
Molecular Probe)[Tucker et al, 2006]. Embryos were imaged with
a Leica DM6000 microscope, Leica camera DFC 360 FX and
Leica LAS AF Software. Images were analysed using the NeuronJ
plugin [33].
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